Results 201 to 210 of about 17,596,321 (231)

Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trial. [PDF]

ESMO Open
Dirven I, Bertels C, Moreels Y, Kessels JI, Vanlaer N, Vander Mijnsbrugge AS, Vounckx M, Dirks I, Raes L, Geeraerts X, Stevens L, von Kemp B, Fasolino G, Awada G, Janssen T, Caljon B, Lefevre T, Everaert H, Rogiers A, Vandemeulebroucke J, Tuyaerts S, Neyns B.   +21 more
europepmc   +1 more source

"I make my own decisions": Views on precision medicine research participation decisions from adults with intellectual disability. [PDF]

HGG Adv
McDonald KE, Banzer E, Cooley M, Singhal R, Goode TD, Kiryluk K, Sabatello M, Project ENGAGE Consortium.   +7 more
europepmc   +1 more source

Neonatal Outcomes Following Preterm Birth Between 28 and 36 Weeks' Gestation in Vietnam: A Cohort Study. [PDF]

Aust N Z J Obstet Gynaecol
Tran QTT, Seeho SK, Nippita TA, Morris JM, Le TQ, Tran HN, Pham HT, Ibiebele I.   +7 more
europepmc   +1 more source

Gui-Shao San Umbilical Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome With Liver Depression and Spleen Deficiency Pattern: A Randomized Controlled Trial. [PDF]

Gastroenterol Res Pract
Zhou M, He Y, Zhang L, Xia J, An Z, Zhang X.   +5 more
europepmc   +1 more source

Upadacitinib for Immune Checkpoint Inhibitor-Related Dermatitis: A Nonrandomized Clinical Trial.

JAMA Oncol
Chen C, Liang X, Peng Z, Zou Y, He H, Zhang X, He Y, Wu S.   +7 more
europepmc   +1 more source

Viestipataljoona 33:n historiikki

Viestimies-lehti, 2017
openaire   +2 more sources

Expediente Vol. 33 n. 1

Clinical and Biomedical Research, 2015
openaire   +3 more sources

Avaliadores Ad hoc n° 33

Extensão em Foco
openaire   +1 more source